|
Subsequent Events - Additional Information (Detail) (USD $)
|
0 Months Ended | ||
|---|---|---|---|
|
Aug. 31, 2014
|
Sep. 26, 2014
Subsequent Event
|
Sep. 26, 2014
Subsequent Event
|
|
| Subsequent Event [Line Items] | |||
| Convertible note financing amount | $ 2,000,000 | ||
| Convertible note, term | 2 years | ||
| Convertible notes, maturity date | Sep. 26, 2016 | ||
| Convertible note, interest rate percentage | 5.00% | ||
| Convertible note, conversion price | $ 0.75 | $ 1.00 | |
| Convertible note, conversion price description | The conversion price is subject to (i) adjustment for stock splits and similar corporate events and (ii) reduction to a price per share that is 10% below the lowest sale price that is below $.9444 per share, for shares of CytoDyn common stock sold in future securities offerings, if any, including sales to AVCP and its designees. | ||
| Percentage reduction to conversion price | 10.00% | ||
| Sale price of common stock | $ 0.9444 | ||
| Warrants to purchase common shares, shares | 250,000 | ||
| Warrants exercise price per share | $ 0.50 | ||
| Warrants, expiration date | Dec. 31, 2019 |
| X | ||||||||||
|
- Definition
Class of warrant or right expiry date of warrant or right exercisable. No definition available.
|
| X | ||||||||||
|
- Definition
Percentage Of Current Conversion Price Lower Than Closing Sale Price No definition available.
|
| X | ||||||||||
|
- Definition
Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period. No definition available.
|
| X | ||||||||||
|
- Definition
The price per share of the conversion feature embedded in the debt instrument. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
|
- Definition
Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
|
- Details
|